LINDSEY ROBINSON: Open Payments
NPI 1992436604 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 26 payments from 13 companies in 2025. Trend: 2023 $231 · 2024 $555 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
| Amgen Inc. | 3 | $45 |
| Novo Nordisk Inc | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Lundbeck LLC | 1 | $24 |
| Abbott Laboratories | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
Products named: Kerendia, AIRSUPRA, PREVNAR 20, REXULTI, OTEZLA, GEMTESA, ELIQUIS, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
